Stage-specific treatment costs for cervical cancer in the United Kingdom.

In order to examine the relationship between stage at initial diagnosis and management costs for cervical cancer, a detailed cost audit over 5 years was conducted on a sample of patients diagnosed in 1990 in one U.K. region. The mean costs of managing pre-invasive carcinoma (386 Pounds) were found to be significantly lower than those of stage 1 invasive carcinoma (6623 Pounds) and both were lower than the costs of invasive cancer at stages 2-4 (10,910 Pounds, 10,579 Pounds and 11,035 Pounds, respectively). A comparison of management costs for cervical cancer with those of breast cancer by stage revealed both that the former are invariably higher and that the cost-by-stage profiles for the two diseases are dissimilar.

[1]  J. Shepherd.  Revised FIGO staging for gynaecological cancer , 1989, British journal of obstetrics and gynaecology.

[2]  D. M. Parkin,et al.  The impact of screening on the incidence of cervical cancer in England and Wales , 1985, British journal of obstetrics and gynaecology.

[3]  J. Habbema,et al.  The management of cervical intra-epithelial neoplasia (CIN): extensiveness and costs in The Netherlands. , 1995, European journal of cancer.

[4]  N. Waugh,et al.  Costs and benefits of cervical screening. II. Is it worthwhile reducing the screening interval from 5 to 3 years? , 1996, Cytopathology : official journal of the British Society for Clinical Cytology.

[5]  M. Fahs,et al.  Cost Effectiveness of Cervical Cancer Screening for the Elderly , 1992, Annals of Internal Medicine.

[6]  D. Eddy.  Screening for cervical cancer. , 1990, Annals of internal medicine.

[7]  M. Koopmanschap,et al.  Care and costs for advanced cervical cancer. , 1992, European journal of cancer.

[8]  D. Whynes,et al.  The Costs of Treating Breast Cancer in the United Kingdom: Implications for Screening , 1998, International Journal of Technology Assessment in Health Care.